Dr Samantha Walker, Director of Research and Innovation at Asthma + Lung UK, the leading lung charity, discusses the socioeconomic costs of lung conditions and the need for great lung health research.
The study, published in Mucosal Immunology, shows the underlying immune mechanisms shared by suppurative lung disease and wheezing despite their differing symptoms.
Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, explores the key challenges in mesothelioma prevention, diagnosis and treatment.
Dr Samantha Walker, Director of Research and Innovation at Asthma + Lung UK, explains why prioritising lung research is the best way to improve the nation’s health.
Paul Sommerfeld, Executive Trustee, TB Alert and Chair, TB Europe Coalition, walks us through tackling tuberculosis. We hear that while there are continuing problems, there are finally grounds for optimism.
Sarah Woolnough, Chief Executive of Asthma + Lung UK, explains which towns and cities are trying to tackle air pollution, reducing the dirty air that causes issues for millions of people with lung conditions.
Dr Erika Kennington, Head of Research and Innovation at Asthma + Lung UK, says that millions of women are drawing the short straw with too little research exploring the effect of female sex hormones on asthma.
Misdiagnoses and delays are far too common for people with lung conditions. Rachel Warren, Senior Policy Officer at Asthma + Lung UK and Policy Lead (Diagnosis) at the Taskforce for Lung Health, explores how new community diagnostic centres could help tackle this issue.
Elize Sturkenboom – van de Wetering, Venture Leader of Lung Oncology at Phillips Healthcare, discusses the diagnosis and treatment of lung cancer through new minimally invasive therapy.
Sarah Woolnough, CEO of Asthma UK and the British Lung Foundation, reflects on landmark research undertaken by the charity ahead of World COPD Day, including the largest ever survey of people with COPD in the UK.
Sarah MacFadyen, Vice Chair of the Taskforce for Lung Health and Head of Policy and External Affairs at Asthma UK and the British Lung Foundation, says it’s time that tobacco dependency was treated just like any other illness.
